Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures
![](https://rheavita.com/wp-content/uploads/2023/03/LNP-mRNA-1-e1680264679811.jpg)
Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures
Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties.
The full article can be read and downloaded here
Please contact us via info@rheavita.com if you wish to learn more about how continuous freeze-drying enables the stabilization of your mRNA therapy for distribution and storage.
For formulation development, the freeze-drying process development, and production, we can be your partner in getting your therapy fast to the market with the highest quality while avoiding cold chain logistics.
![](https://rheavita.com/wp-content/uploads/2023/04/Scherm%C2%ADafbeelding-2023-04-17-om-15.50.41.png)
For the most up to date news, please follow us on LinkedIn via the link below